Cargando…

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands

The present study investigated the in vitro pharmacology of the human kappa opioid receptor using multiple assays, including calcium mobilization in cells expressing chimeric G proteins, the dynamic mass redistribution (DMR) label-free assay, and a bioluminescence resonance energy transfer (BRET) as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sturaro, Chiara, Malfacini, Davide, Argentieri, Michela, Djeujo, Francine M., Marzola, Erika, Albanese, Valentina, Ruzza, Chiara, Guerrini, Remo, Calo’, Girolamo, Molinari, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068900/ https://www.ncbi.nlm.nih.gov/pubmed/35529436 http://dx.doi.org/10.3389/fphar.2022.873082

Ejemplares similares

Novel Mixed NOP/Opioid Receptor Peptide Agonists
por: Pacifico, Salvatore, et al.
Publicado: (2021)

Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist
por: Rizzi, Anna, et al.
Publicado: (2016)

Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies
por: Ruzza, Chiara, et al.
Publicado: (2018)

In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative
por: Ruzza, Chiara, et al.
Publicado: (2015)

Functional selectivity of EM-2 analogs at the mu-opioid receptor
por: Piekielna-Ciesielska, Justyna, et al.
Publicado: (2023)

Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists
por: Azevedo Neto, Joaquim, et al.
Publicado: (2021)

Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1–13)-NH(2)
por: Pacifico, Salvatore, et al.
Publicado: (2020)

Structure–Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity
por: Albanese, Valentina, et al.
Publicado: (2021)

NOP receptor pharmacological profile – A dynamic mass redistribution study
por: Malfacini, Davide, et al.
Publicado: (2018)

(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky ‘Forced-Traceless’ Regioselective Pd-Catalyzed C(sp(2))–H Activation
por: Illuminati, Davide, et al.
Publicado: (2023)

Pharmacological profiles of opioid ligands at Kappa opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2006)

In vitro pharmacological characterization of a novel unbiased NOP receptor‐selective nonpeptide agonist AT‐403
por: Ferrari, Federica, et al.
Publicado: (2017)

Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo)
por: Bird, Mark F., et al.
Publicado: (2016)

Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors
por: Wtorek, Karol, et al.
Publicado: (2019)

Evaluation of [Cys(ATTO 488)(8)]Dermorphin-NH(2) as a novel tool for the study of μ-opioid peptide receptors
por: Giakomidi, Despina, et al.
Publicado: (2021)

Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
por: Schmidhammer, Helmut, et al.
Publicado: (2020)

Structure- and conformation-activity studies of nociceptin/orphanin FQ receptor dimeric ligands
por: Pacifico, Salvatore, et al.
Publicado: (2017)

Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor
por: Ben Haddou, Tanila, et al.
Publicado: (2014)

Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors
por: Wtorek, Karol, et al.
Publicado: (2022)

Biased versus Partial Agonism in the Search for Safer Opioid Analgesics
por: Azevedo Neto, Joaquim, et al.
Publicado: (2020)

In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay
por: Ruzza, C., et al.
Publicado: (2023)

Identification of novel ligands interacting with kappa opioid receptors
por: Spetea, Mariana, et al.
Publicado: (2011)

Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny
por: Smith, Francine G., et al.
Publicado: (2011)

Behavioral Pharmacology of Novel Kappa Opioid Receptor Antagonists in Rats
por: Page, Sarah, et al.
Publicado: (2019)

Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2
por: Malfacini, D., et al.
Publicado: (2015)

Pharmacology, Physiology and Genetics of the Neuropeptide S System
por: Reinscheid, Rainer K., et al.
Publicado: (2021)

Editorial: Kappa opioid receptors revealed: Disentangling the pharmacology to open up new therapeutic strategies
por: Walwyn, Wendy Margaret, et al.
Publicado: (2022)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans
por: Emendato, Alessandro, et al.
Publicado: (2018)

Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin
por: D’Accolti, Maria, et al.
Publicado: (2023)

Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family
por: Morse, Megan, et al.
Publicado: (2013)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
por: Peckham, Alyssa M., et al.
Publicado: (2018)

Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines
por: Nicoli, Francesco, et al.
Publicado: (2021)

Structure of the human kappa opioid receptor in complex with JDTic
por: Wu, Huixian, et al.
Publicado: (2012)

Major Depressive Disorder and Kappa Opioid Receptor Antagonists
por: Li, Wei, et al.
Publicado: (2016)

Kappa Opioids, Salvinorin A and Major Depressive Disorder
por: Taylor, George T., et al.
Publicado: (2016)

The Kappa Opioid Receptor: From Addiction to Depression, and Back
por: Lalanne, Laurence, et al.
Publicado: (2014)

Kappa Opioid Receptor on Pulmonary Macrophages and Immune Function
por: Zeng, Si, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3qnosr4s3l74eu7rcqnrc6uu2b